The new venture, Ecron Acunova Company, would give Acunova entry into South East Asian countries.
Bangalore, Jan. 7
The Manipal group-owned clinical research organisation Ecron Acunova has formed a joint venture contract research organisation (CRO) in Thailand with the Bangkok-based Jamjuree Innovations Co Ltd.
Ecron Acunova has taken a controlling 74 per cent stake in the CRO and has invested an initial Rs 5 crore in it, Mr D.A. Prasanna, Founder and Chairman of EA, said.
The new venture, Ecron Acunova Company Ltd, based in Bangkok, would give Acunova entry into South East Asian countries and aim to become a leading regional CRO, a company release said.
JJI is a 100 per cent subsidiary of Chulalongkorn University Intellectual Property Foundation and has strong ties with the University's Faculty of Medicine, including Clinical Research Centre (Chula CRC).
Mr Prasanna said, “South-East Asia is a key market. As sponsors increasingly include Southeast Asia in drug development programmes, it is imperative for us to establish our operations in collaboration with regional experts like Chulalongkorn University. With this joint venture with JJI, our execution synergy is enhanced...”
EA has presence in Europe and the US and brings over two decades of clinical research experience in Phase I-IV trials and related activities. Chula CRC brings additional experience in HIV research in Thailand and SEA region.
EACL's CEO, Dr Eugene Kroon, said a centre of excellence to conduct studies in nutrition and HIV would be set up in Bangkok. EACL will offer services in Thailand, Malaysia, Vietnam and Cambodia and later expand to other countries in the region.
Dr Kiat Ruxrungtham, Professor of Medicine, Chulalongkorn University and Chairman of EACL, said, “JJI has built expertise in regional quality clinical research over the last three years, conducting clinical trials for international sponsors in Thailand, Malaysia and Vietnam. We look forward to further expanding this model of hands-on local study and investigator relationship management in South-East Asia through the joint venture.”